about
CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severityInhaled antibiotics for long-term therapy in cystic fibrosisNebulised anti-pseudomonal antibiotics for cystic fibrosisThe proteomics of lung injury in childhood: challenges and opportunitiesEicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cellsA novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.Is CFTR-delF508 really absent from the apical membrane of the airway epithelium?Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells.Transplantation for cystic fibrosis: outcome following early liver transplantation.Chloride channels in the kidney: lessons learned from knockout animals.Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.Bicarbonate transport proteins.Diversity and significance of Burkholderia species occupying diverse ecological niches.Macromolecular interactions and ion transport in cystic fibrosis.Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator.Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets.Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials.Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.Defective activation of c-Src in cystic fibrosis airway epithelial cells results in loss of tumor necrosis factor-alpha-induced gap junction regulation.Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells.Myeloperoxidase and protein oxidation in cystic fibrosis.Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: a case report.Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.Long-term oropharyngeal colonization by C. albicans in children with cystic fibrosis.Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.Malnutrition in adults with cystic fibrosis.Acceptance and well-being in adolescents and young adults with cystic fibrosis: a prospective study.Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome.The role of acceptance in psychological functioning in adolescents with cystic fibrosis: a preliminary study.Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study.Highly efficient anion transport mediated by 1,3-bis(benzimidazol-2-yl)benzene derivatives bearing electron-withdrawing substituents.Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR.Exercise Capacity in Prepubertal Children with Cystic Fibrosis
P2860
Q21261465-EF077F50-8011-4850-873B-2440A7B483CBQ24235635-9E759A4A-94D4-4972-A9B2-9CF50BC8C4B4Q24247996-A0AAF179-804B-469F-B697-93F243426A77Q26765104-6847D7A1-C347-4A1D-81FD-0BB04CDFD7A7Q33511751-194B5702-1413-4E3C-B5D9-47E137ED242BQ33515286-9E491B58-3185-416A-AB1A-C0E06354EB28Q33986166-29B0317B-78BD-4D42-8591-ED6237149477Q34123969-0F18110C-8633-4BB6-831D-9AA3B52FB9F3Q34609666-F5082CE1-3482-465B-A274-1EE44C37686DQ34993939-9A991D80-222C-4217-AAA1-3F2F40EAACF2Q34998656-B73A9D9B-1675-4161-914F-E2ACAB0A2DFDQ35003109-585AEBEC-187B-46BC-9730-28EACA1B4261Q35200150-B9CFF5F1-3B69-4A59-9568-AE55C7026D8AQ35901540-F1404DFF-CC1D-4FD7-8415-2A075005828DQ36052358-8992C165-C4B6-4ED9-BED0-54A4DB1F6A69Q37596433-46BDC9AE-7A04-494B-8B01-C34208A95830Q38099053-D255DC3F-6C6D-43B0-9127-C05F95D9CEE1Q38358856-E0509212-55B1-4A32-B7D5-E287C2483390Q40680220-4AA2A613-6C0B-4BBE-8C00-A43342FC29F3Q40766072-5DF54340-CAD4-4FF7-9618-FA0050B0CB23Q40859174-1DD9D4E4-D242-4C2A-B131-3289CA4AA6D3Q41927455-28768D70-51DB-476A-84C7-1A18BA304871Q44834295-3ACA92B5-7430-461C-BB80-95784641F65BQ45039401-B13CFFB6-C7AC-4E73-9194-31FB4C38C1A4Q46453243-97D4F12D-3301-4E99-8D1E-217D4580EE90Q47926780-CDAC2FF2-F341-41CA-9BD8-236CCD615249Q48713946-46C7EE6B-9035-4A04-ACB9-3E8179955770Q49041963-E446D53E-E2C4-4FCC-ABA8-7544D813B5A8Q49161085-A2702FFB-4B93-4F03-AE35-9A566D0F7595Q51673640-58103B29-FC4F-4F5F-B723-99336758BAE5Q54511191-15014857-4AAB-407C-815D-BED052462A52Q55030853-F5BE2101-5243-47BC-A474-5301B5C2CD75Q58691288-6813D35E-71B6-481B-AFF7-26427C97D217
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im Januar 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 1998
@en
наукова стаття, опублікована в січні 1998
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Cystic fibrosis
@en
type
label
Cystic fibrosis
@en
prefLabel
Cystic fibrosis
@en
P1433
P1476
Cystic fibrosis
@en
P2093
B J Rosenstein
P304
P356
10.1016/S0140-6736(97)09174-5
P407
P577
1998-01-01T00:00:00Z